Atlas Trials

A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer

Clinical trial NCT06283134 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06283134
Sponsor
China Medical University, China
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Colorectal Cancer Metastatic
Start date
2026-03-01
Primary completion
2027-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.